Sadhana Nitro Chem Promoters Secure Court Injunction Against Share Sales by Broking Firms Aug 18, 2025
More news about Sadhana Nitrochem
14Aug 25
Catalyst Trusteeship Reduces Stake in Sadhana Nitrochem Through Sale of Invoked Shares
Catalyst Trusteeship, acting as Security Trustee for lenders, sold 72,46,119 invoked equity shares of Sadhana Nitrochem Limited on August 11, 2025. This reduced Catalyst's holding from 8.22% to 6.02% of the total share capital, a 2.20 percentage point decrease. The transaction was disclosed in compliance with SEBI regulations. Sadhana Nitrochem also announced recent management changes, including the resignation of CFO Rakesh Raichand Kothari and appointments of Vimal Jain as President and Jayesh Shah as Vice President of Operations and Finance.
11Aug 25
Catalyst Trusteeship Invokes 8.23% Stake in Sadhana Nitrochem Through Pledged Shares
Catalyst Trusteeship Limited has invoked 2.71 crore equity shares (8.23%) of Sadhana Nitrochem Limited on August 7, 2025. The shares were previously pledged by Manekchand Panachand Trading Investment Co Pvt Ltd. Catalyst Trusteeship acted as Security Trustee for a lender. The invocation was disclosed on August 11, 2025, in compliance with SEBI regulations. Sadhana Nitrochem's total paid-up equity share capital remains unchanged at 32.94 crore shares of INR 1 each.
Sadhana Nitro Chem Ltd. reported a significant increase in Q4 consolidated net profit to ₹41.00 crore, up from ₹5.00 crore year-over-year, despite a 23.30% decrease in revenue to ₹494.70 crore. The company's operating profit margin improved to 26.68% from 14.42% in the same quarter last year. For FY2024-25, annual revenue rose 33.70% to ₹1,940.00 crore, with net profit increasing 28.12% to ₹41.00 crore. The results indicate enhanced operational efficiency and cost management, offsetting revenue challenges.
Sadhana Nitro Chem Limited announced impressive Q4 results with net profit soaring 720% YoY to ₹41.00 crore, despite a 23.3% revenue decline to ₹494.70 crore. EBITDA grew 42.4% to ₹132.30 crore, with margins improving to 26.74%. The board recommended a 10% dividend and made key auditor appointments. The company's Rights Issue proceeds of ₹20.39 crore are being utilized as planned.